14/10/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

14/10/2023

Oct 14, 2023, 22:16 | Blog
Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter: "So…
Oct 14, 2023, 22:07 | Blog
Johanna Joyce: Excited for Drs. Ángel Álvarez-Prado and Spencer Watson, two wonderful postdocs in my lab, who are now on the job market.
Johanna Joyce, Professor at University of Lausanne - UNIL, made the following post on LinkedIn:…
Oct 14, 2023, 21:59 | Blog
The U-Link Canada team is at SIOP2023 in Ottawa! - U-Link Canada
U-Link Canada, made the following post on LinkedIn: "The U-Link Canada team is at SIOP2023…
Oct 14, 2023, 21:53 | Opinion
Biljana Naumovic: Building equitable access should be an all-encompassing priority – not an afterthought or a last step.
Biljana Naumovic, Worldwide Vice President Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson…
Oct 14, 2023, 21:44 | Blog
This unique alliance with Takeda aims to accelerate the development of novel treatments to bring groundbreaking cancer research discoveries to patients. - The Mark Foundation for Cancer Research
Oct 14, 2023, 21:38 | Blog
Maite Gorostegui: The SIOP Global Mapping Programme is now a reality...from "Tijuana to Tierra del Fuego" in Latin America (more than 200 centeres) and more than 100.
Maite Gorostegui, Pediatric Oncologist at Pediatric Cancer Center Barcelona, shared a post by Jennifer Geel,…
Oct 14, 2023, 18:26 | Blog
The House approves $25M for NF; onward to the Senate! - Children's Tumor Foundation
Rebecca Brown, Assistant Professor at The Mount Sinai Hospital, shared a post by Children's Tumor…
Oct 14, 2023, 18:26 | Blog
VIGex: a VHIO-developed predictive, pan-cancer platform to help guide patient selection for personalized immunotherapy. - Vall d'Hebron Institute of Oncology
Quoting Vall d'Hebron Institute of Oncology on LinkedIn: "VIGex: a VHIO-developed predictive, pan-cancer platform to…
Oct 14, 2023, 18:25 | Blog
Paul Pearlman: In case you missed them, here are the funding solicitations announced at the Grand Challenges meeting this week.
Paul Pearlman, Program Director/Lead for Global Health Technology at NCI, recently shared on LinkedIn: "In…
Oct 14, 2023, 18:24 | Career
Chantal Maertens: I’m happy to share that I’m starting a new position as Medical Lead New Indications Rare Diseases and Rare Blood Disorders North Europe at Sanofi!
Chantal Maertens, Medical Lead New Indications Rare Diseases and Rare Blood Disorders North Europe at…
All: 29 Posts: 1 - 10